RBC Capital Initiates Coverage On Thorne HealthTech with Outperform Rating, Announces Price Target of $11
RBC Capital analyst Sean Dodge initiates coverage on Thorne HealthTech (NASDAQ:THRN) with a Outperform rating and announces Price Target of $11.